Articles related to CANCER SCREENING

The American College of Physicians issued updated breast cancer screening guidance recommending biennial mammography for average-risk women aged 50 to 74, with shared decision-making for those 40 to 49 and discontinuation discussions after 74.

TNF-alpha inhibitor exposure was associated with adjusted hazard ratios of 1.99 for basal cell carcinoma, 1.69 for squamous cell carcinoma, and 1.54 for melanoma in a 56,209-patient retrospective cohort.

ACP updated guidance recommends shared decision-making rather than routine biennial mammography for average-risk women aged 40 to 49, diverging from the USPSTF recommendation.

Breast cancer screening remains a persistent area of variation in clinical practice. Updated guidance from the American College of Physicians aims to clarify when screening offers meaningful benefit for average‑risk patients — and when it may not.

Supplemental MRI for women with extremely dense breasts and higher-than-average risk “could be cost-effective if MRI costs and false-positive biopsy rates are reduced.” — Tosteson et al., Annals of Internal Medicine

“A lot of our individuals are young, so we’ve seen this cancer being diagnosed during or after pregnancy, and often it gets labeled as hemorrhoids … but in hindsight, probably should have warranted attention earlier.” – Pashtoon Kasi, MD